Drug

Entrectinib

38 flagged reaction(s) · 922 total co-reports · max PRR 45.7

Important: Reactions below are the flagged terms from this drug’s FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate disproportionality in spontaneous reporting, not causation. Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.

	Reaction	Co-reports (a)	PRR	ROR	Signal
1	Metastases To Central Nervous System	46	45.7	47.0	signal
2	Taste Disorder	71	45.1	47.1	signal
3	Ataxia	29	30.9	31.5	signal
4	Ejection Fraction Decreased	21	17.1	17.3	signal
5	Myocarditis	14	15.7	15.8	signal
6	Metastases To Liver	21	15.2	15.4	signal
7	Disease Progression	117	12.6	13.5	signal
8	Blood Creatinine Increased	62	12.0	12.5	signal
9	Cardiomyopathy	13	11.2	11.2	signal
10	Ageusia	21	10.7	10.8	signal
11	Cognitive Disorder	39	10.6	10.9	signal
12	Hypoaesthesia Oral	12	10.1	10.2	signal
13	Pericardial Effusion	18	9.9	10.0	signal
14	Renal Impairment	60	9.1	9.4	signal
15	Urinary Retention	22	8.4	8.5	signal
16	Pneumonitis	17	8.0	8.1	signal
17	Cardiac Failure	49	7.7	7.9	signal
18	Pancytopenia	32	7.3	7.4	signal
19	Carpal Tunnel Syndrome	8	7.2	7.3	signal
20	Ventricular Tachycardia	9	6.9	6.9	signal
21	Neurotoxicity	9	6.6	6.6	signal
22	Hospice Care	5	6.4	6.5	signal
23	Hepatic Function Abnormal	18	6.2	6.2	signal
24	Dysgeusia	36	6.1	6.2	signal
25	Pain Of Skin	13	6.1	6.1	signal
26	Blood Creatine Phosphokinase Increased	13	5.6	5.7	signal
27	Brain Neoplasm	4	5.5	5.5	signal
28	Drug Resistance	11	5.4	5.5	signal
29	No Adverse Event	71	5.1	5.3	signal
30	Central Nervous System Lesion	5	4.6	4.6	signal
31	Pericarditis	6	4.6	4.6	signal
32	Metastases To Lung	4	4.4	4.4	signal
33	Neoplasm Progression	12	4.3	4.4	signal
34	Interstitial Lung Disease	16	4.2	4.2	signal
35	Haematotoxicity	3	4.1	4.1	signal
36	Ischaemic Stroke	5	3.5	3.6	signal
37	Lung Neoplasm Malignant	7	2.1	2.2	no signal
38	Product Complaint	3	1.5	1.5	no signal